AXQ Capital’s Repligen RGEN Stock Holding History

AXQ Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,494	Closed	-$371K	–	595
2024 Q3	$371K	Buy	+2,494	New	+$358K	0.11%	306
2024 Q1	–	Sell	-1,400	Closed	-$252K	–	841
2023 Q4	$252K	Sell	1,400 -319	-19%	-$49.7K	0.07%	438
2023 Q3	$273K	Buy	+1,719	New	+$281K	0.1%	337
2023 Q2	–	Sell	-1,300	Closed	-$219K	–	516
2023 Q1	$219K	Buy	+1,300	New	+$232K	0.09%	390

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

AXQ Capital's RGEN Position: Q4 2024 in Review

AXQ Capital sold out of Repligen (RGEN) in Q4 2024, closing a stake of 2,494 shares — an estimated $371K sold.

AXQ Capital first reported a position in RGEN in Q1 2023 and held it in 4 quarters. The position peaked at $371K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

AXQ Capital reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
AXQ Capital sold 2,494 Repligen shares in Q4 2024, an estimated $371K.
AXQ Capital first reported a position in Repligen in Q1 2023 and held it in 4 quarters.
AXQ Capital's Repligen position peaked at $371K in Q3 2024.
431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on AXQ Capital's 13F filing for Q4 2024, filed 11 Feb 2025.